March 13, 2018
Hemogenyx expands deal with US biotech company for quarter million USD
Hemogenyx Pharmaceuticals has ensured a continuation of a pact with a major US biotechnology company for filing of a provisional patent…
Pharmaceuticals, Biotechnology and Life Sciences
Category: news
March 12, 2018
Novartis reshuffles senior leadership chairs, splits operations into technical operations and business services
Novartis has made several changes as it added several figures in the team starting April, while its Operations president, André…
March 12, 2018
Portola Pharmaceuticals appoints Moriarty as legal officer
Portola Pharmaceuticals has appointed John B. Moriarty, J.D., as executive vice president and general counsel, who will report to William…
March 8, 2018
GSK, Innoviva get EC’s label update, once daily Relvar Ellipta as good as as twice-daily ICS/LABA for patients with asthma
The European Commission has approved a label update for the use of GlaxoSmithKline and Innoviva’s Relvar Ellipta, an inhaled corticosteroid (ICS) / long-acting β2-agonist (LABA)…
March 8, 2018
N4 Pharma assigns ex AstraZeneca senior research scientist to lead Nuvec, its lead vaccine delivery program.
N4 Pharma has recruited a former AstraZeneca senior research scientist to lead the Nuvec, its lead vaccine delivery program.
March 8, 2018
Sanofi, Evotec to accelerate infectious disease R&D with new open innovation platform
Evotec and Sanofi have entered exclusive talks to create an Evotec-led Infectious Disease open innovation R&D platform, the companies said…
March 8, 2018
BASF in exclusive talks with Bayer to acquire vegetable seeds business
BASF is in exclusive talks to acquire Bayer’s entire vegetable seeds business, operating under the global trademark Nunhems, said BASF…
March 7, 2018
Novartis to advance virtual clinical trials program with expanded alliance
Novartis aims to initiate up to 10 new clinical trials over the next three year with a leader in decentralized clinical trial…
March 7, 2018
Sonoma Pharmaceuticals nets $4.6 million after closing of public offering of common stock
Sonoma Pharmaceuticals got near $4.6 million from an offering of 1,428,570 shares for price of $3.50 per share, after deducting…
March 6, 2018
Amryt expands Lojuxta reach in the Middle East with a deal with Pharon Healthcare
Amryt has expanded its market coverage for Lojuxta with an exclusive distribution agreement for Lebanon, Jordan and Syria, as it…